Biosante Pharmaceuticals, Inc.

(NASDAQ:BPAX)

Key Stats & Ratios

Valuation
Market Cap 99.93M
P/E
P/E (Trailing)
P/E (Forward) -4.00
Price/Sales 30.10
Price/Book 4.54
EPS -1.44
EPS Growth (ttm) -100.00%
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income -52.32M
Net Income -54.02M
Profit Margin (ttm)
Operating Margin (ttm) -15.08%
Management Effectiveness
Return on Assets (ttm) -114.20%
Return on Equity (ttm)
EBIT Margin (ttm)
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 85.82M
Revenue 3.47M
Revenue/Share 0.05
Revenue Growth (ytd) 3252.80%
Annual Revenue Growth Rate (3Y) -24.97%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 3.47M
EBITDA -22.98M
Diluted EPS (ttm) -1.44
Balance Sheet
Total Cash 41.00M
Total Cash/Share 0.64
Total Assets 47.32M
Total Liabilities 24.31M
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.79
Current Ratio 6.00
Leverage Ratio 2.00
Book Value/Share 0.36
Cash Flow
Cash Flow -53.86M
Free Cash Flow -6.17M
Cash Flow/Share -0.84
Free Cash Flow/Share -0.10

Trading Information

Stock Price History
Beta 0.64
52Wk Change -4.20%
52Wk Change Vs. Mkt -12.00%
52Wk High 2.70
52Wk Low 1.33
10 Day Moving Average 1.65
200 Day Moving Average 1.76
Share Statistics
Average Volume 282.90K
Shares Outstanding 64.06M
Shares Float 60.95M
% Held by Insiders 9.80%
% Held by Institutions 22.00%
Shares Short (As of Mar 15, 2010) 1.86M
Short Ratio 1.90
Short % of Float 6.50%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount
- Advertisement -